US Carrier Screening Market (2023-2028)
The US Carrier Screening Market was valued at $1108.2 Million in 2023 and projected to reach to $2978.3 Million by 2028, representing a compound annual growth rate of 21.9%. The US carrier screening market is positioned for sustained high-growth trajectory through 2028, fueled by technological innovations in genetic testing, rising healthcare expenditures, and proactive preventive medicine adoption.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Carrier Screening Market Trends and Insights
- This accelerated growth in the US reflects increasing adoption of genetic testing technologies, heightened awareness of hereditary disease risks, and expanding insurance coverage for carrier screening services.
- The US market is driven by advances in next-generation sequencing (NGS) platforms, growing demand for preconception and prenatal screening, and the integration of carrier screening into routine clinical practice across major healthcare systems. In the US, carrier screening has transitioned from a niche specialty service to a mainstream preventive healthcare offering, supported by clinical guidelines from major organizations and improved accessibility through direct-to-consumer and healthcare provider channels.
- The US market benefits from strong healthcare infrastructure, significant investment in genetic testing innovation, and a large population seeking proactive disease prevention strategies.
- Between 2023 and 2028, the US carrier screening market is expected to capture substantial growth as reimbursement policies expand, test panels broaden to include more genetic conditions, and patient education initiatives drive demand across diverse demographic segments..
Key Market Statistics
- CAGR (2023-2028) 21.9% CAGR
- Market Size, 2023 ~USD 1108.2 Million
- Forecast, 2028 ~USD 2978.3 Million
- Country US
US Carrier Screening Market Overview
Rapid Market Expansion :
The US carrier screening market is experiencing exceptional growth, expanding from $1,108.2 million in 2023 to a projected $2,978.3 million by 2028, driven by technological advancements and increased genetic testing adoption across American healthcare systems.
Strong CAGR Performance :
At 21.9% CAGR, the US market is outpacing the global average of 19.7%, indicating accelerated demand for carrier screening services within the United States healthcare landscape and stronger market penetration than international counterparts.
Insurance Coverage Expansion :
Growing insurance reimbursement policies and expanded coverage for carrier screening tests are significantly lowering patient barriers to access, making genetic testing more affordable and accessible across diverse US demographic segments.
Heightened Disease Risk Awareness :
Increased consumer awareness of hereditary disease risks and preventive healthcare trends are driving demand for carrier screening among prospective parents and individuals with family histories of genetic conditions in the US market.
US Carrier Screening Market Dynamics
- Healthcare providers and diagnostic laboratories are increasingly integrating carrier screening into routine prenatal and preconception care protocols, expanding the addressable patient population.
- Regulatory support and evolving clinical guidelines further strengthen market fundamentals.
- The 21.9% CAGR reflects strong institutional and consumer demand dynamics specific to the US healthcare ecosystem.
- Market consolidation among diagnostic service providers and strategic partnerships between genetic testing companies and healthcare systems will likely accelerate market penetration and service accessibility across urban and rural American markets through 2028..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The US carrier screening market is valued at $1,108.2 million in 2023 and will reach $2,978.3 million by 2028, growing at 21.9% CAGR.
- The US market is driven by adoption of NGS technology, expanded insurance coverage, and integration into routine clinical practice.
- In the US, carrier screening has evolved from specialty service to mainstream preventive healthcare with broad accessibility.
- The US market growth is supported by clinical guidelines, reimbursement expansion, and increasing patient awareness of hereditary disease risks.
Carrier Screening Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | PULMONARY CONDITIONS (Medical Condition) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 19.7% from 2023 to 2028 |
| Largest Segment | SERVICES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 2.2 (2023) |
| Revenue Forecast (Billions) | ~USD 5.4 (2028) |
| Segments Covered | Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028 |
US Carrier Screening Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Products
- Services
By Type
- Customized Panel Testing
- Expanded Carrier Screening
- Predesigned Panel Testing
- Targeted Disease Carrier Screening
By Medical Condition
- Hematological Conditions
- Neurological Conditions
- Other Medical Conditions
- Pulmonary Conditions
By Technology
- Dna Microarrays
- Dna Sequencing
- Other Technologies
- Pcr
By End User
- Clinical Laboratories
- Fertility Clinics
- Hospitals And Medical Centers
- Other End Users
By Product & 2021-2028
- Products
- Services
US: CARRIER SCREENING MARKET, BY END USER, 2021–2028
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 189.4 | 227.6 | 275.7 | 333.7 | 403.7 | 488.8 | 591.6 | 722.5 | 21.3 |
| FERTILITY CLINICS | 76.9 | 91.1 | 108.6 | 129.5 | 154.3 | 184 | 219.3 | 263.8 | 19.4 |
| HOSPITALS AND MEDICAL CENTERS | 448.5 | 546.3 | 670.4 | 822.1 | 1007.5 | 1235.1 | 1513.4 | 1870.9 | 22.8 |
| OTHER END USERS | 39 | 45.5 | 53.5 | 62.9 | 73.9 | 86.9 | 102.1 | 121 | 17.7 |
| TOTAL | 753.9 | 910.5 | 1108.2 | 1348.2 | 1639.4 | 1994.7 | 2426.4 | 2978.3 | 21.9 |
Target Audience
- Diagnostic Laboratory Operators : Need US market sizing and growth forecasts to evaluate expansion opportunities, justify capital investments in genetic testing infrastructure, and benchmark performance against market growth trajectories.
- Healthcare System Administrators : Require market intelligence on carrier screening adoption rates, insurance coverage trends, and patient demand patterns to inform service integration decisions and prenatal care program development across US hospital networks.
- Genetic Testing Technology Vendors : Seek detailed US market data to identify addressable market segments, assess competitive positioning, and develop targeted sales strategies for carrier screening platforms and diagnostic solutions.
- Investment & Private Equity Firms : Need validated US market forecasts and growth metrics to evaluate investment opportunities in genetic testing companies, diagnostic service providers, and healthcare technology firms operating in the carrier screening space.
- Insurance & Payer Organizations : Require market analysis on carrier screening utilization trends, cost-benefit data, and reimbursement landscape to inform coverage policies, pricing strategies, and preventive care program development in the US market.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation ($1,108.2M in 2023) and verified 5-year forecast data to support strategic planning, investment decisions, and competitive positioning within the American carrier screening sector.
- Regional Performance Benchmarking : Compare US market dynamics against global trends (21.9% vs. 19.7% CAGR) to identify competitive advantages, market maturity levels, and growth acceleration opportunities specific to the American healthcare landscape.
- Insurance & Reimbursement Insights : Access detailed analysis of expanding US insurance coverage policies, reimbursement trends, and payer dynamics driving carrier screening adoption and market accessibility across American patient populations.
- Strategic Market Entry Planning : Leverage comprehensive US market intelligence to develop targeted go-to-market strategies, identify high-growth segments, and optimize resource allocation for diagnostic companies and healthcare providers entering or expanding in America.
- Stakeholder Decision Support : Equip executives, investors, and healthcare administrators with credible US market data to justify budget allocations, support board presentations, and inform long-term strategic initiatives in genetic testing services.
Frequently asked questions
What is the current size of the US carrier screening market?
The US carrier screening market was valued at $1,108.2 million in 2023 and is expected to grow to $2,978.3 million by 2028.
What is the projected growth rate for the US carrier screening market?
The US carrier screening market is projected to grow at a compound annual growth rate (CAGR) of 21.9% from 2023 to 2028.
What factors are driving growth in the US carrier screening market?
Key drivers in the US include advances in NGS technology, expanded insurance coverage, clinical guideline adoption, increased patient awareness, and integration into routine healthcare practice.
How has carrier screening adoption changed in the US?
In the US, carrier screening has transitioned from a specialty service to mainstream preventive healthcare, with improved accessibility through both healthcare providers and direct-to-consumer channels.
What is expected to fuel US carrier screening market expansion through 2028?
The US market expansion is expected to be fueled by broadening test panels, reimbursement policy expansion, patient education initiatives, and growing demand for preconception and prenatal screening.
RESEARCH METHODOLOGY
The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).
The following is a breakdown of the primary respondents:
Breakdown of Primary Participants:
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.
Market Definition
Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.
Market Stakeholders
- Carrier screening product manufacturers, vendors, and distributors
- Carrier screening service companies
- Hospitals and private physician clinics
- Reference laboratories
- Donor banks
- Health insurance payers
- Research & consulting firms
- Diagnostic Centers, and Medical Colleges
- Research Institutes
- Clinical Laboratories
- Distributors of Carrier Screening Products and services
Report Objectives
- To define, describe, and forecast the global Carrier Screening Market based on Product & Service, Type, Medical Condition, Technology, End User, and Region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the Carrier Screening Market.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company
- Geographic Analysis: Further breakdown of the European Carrier Screening Market into specific countries.
Get the Full Carrier Screening Market Report
Full forecast, segment splits, and company analysis for all Carrier Screening Market.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
